Publications found:
43,378
Sort by:
2013 US Microbiology Testing Market: Opportunities and Strategies for Suppliers
US$ 7,520.00
... 1,037-page report from Venture Planning Group presents a comprehensive analysis of the US microbiology testing market, including: Major issues pertaining to the ... on the definition, epidemiology, and etiology of major infectious diseases and microorganisms. Ten-year test volume and sales forecasts for nearly ...
January 2013
1037 pages
US Telelaparoscopy Opportunity Analysis
US$ 1,000.00
... Our extensive research and analysis have led us to identify three areas, where unlimited opportunities lie. Amongst these, “US Telelaparoscopy Opportunity Analysis”, provides insights on the Telelaparoscopy general surgery. Presented in 25 slides, this report unfolds the tremendous scope of Telelaparoscopy - ...
December 2012
25 pages
Disease Management and Health Monitoring for ACOs 1Q 2013
US$ 3,500.00
... ) and Accountable Care Organization (ACO). It analyzes how care management services and home health monitoring technologies will be deployed in these new care services ... ACO structure and operational models will influence adoption of care management service and health monitoring technologies.”
December 2012
68 pages
2013 French Hospital Cancer Diagnostics Market
US$ 3,080.00
This new report from Venture Planning Group contains 533 pages, 43 tables, and presents a comprehensive analysis of the French hospital cancer diagnostics market, including: Major issues pertaining to the French hospital laboratory practice, as well as key economic, ...
December 2012
533 pages
2013 German Hospital Cancer Diagnostics Market
US$ 3,080.00
This new report from Venture Planning Group contains 533 pages, 40 tables, and presents a comprehensive analysis of the German hospital cancer diagnostics market, including: Major issues pertaining to the German hospital laboratory practice, as well as key economic, ...
December 2012
533 pages
2013 Italian Hospital Cancer Diagnostics Market
US$ 3,080.00
This new report from Venture Planning Group contains 525 pages, 38 tables, and presents a comprehensive analysis of the Italian hospital cancer diagnostics market, including: Major issues pertaining to the Italian hospital laboratory practice, as well as key ...
December 2012
525 pages
2013 Japanese Hospital Cancer Diagnostics Market
US$ 3,880.00
This new report from Venture Planning Group contains 537 pages, 42 tables, and presents a comprehensive analysis of the Japanese hospital cancer diagnostics market, including: Major issues pertaining to the Japanese hospital laboratory practice, as well as key ...
December 2012
537 pages
2013 Spanish Hospital Cancer Diagnostics Market
US$ 3,080.00
This new report from Venture Planning Group contains 521 pages, 41 tables, and presents a comprehensive analysis of the Spanish hospital cancer diagnostics market, including: Major issues pertaining to the Spanish hospital laboratory practice, as well as key ...
December 2012
521 pages
2013 UK Hospital Cancer Diagnostics Market
US$ 3,080.00
This new report from Venture Planning Group contains 527 pages, 37 tables, and presents a comprehensive analysis of the UK hospital cancer diagnostics market, including: Major issues pertaining to the UK hospital laboratory practice, as well as key economic, regulatory, demographic, social and ...
December 2012
527 pages
2013 US Hospital Cancer Diagnostics Market
US$ 5,200.00
This new report from Venture Planning Group contains 567 pages, 50 tables, and presents a comprehensive analysis of the US hospital cancer diagnostics market, including: Major issues pertaining to the US laboratory practice, as well as key economic, regulatory, demographic, social and technological trends ...
December 2012
567 pages
2013 France Clinical Chemistry and Immunodiagnostics Markets
US$ 4,320.00
... and ten-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays ... and their potential market applications. Product development opportunities for clinical chemistry and immunodiagnostic instruments and consumables. Profiles of 25 current and ...
December 2012
542 pages
2013 Germany Clinical Chemistry and Immunodiagnostics Markets
US$ 4,320.00
... ten-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays ... and their potential market applications. Product development opportunities for clinical chemistry and immunodiagnostic instruments and consumables. Profiles of 25 current and ...
December 2012
578 pages
2013 Italy Clinical Chemistry and Immunodiagnostics Markets
US$ 4,320.00
... ten-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays ... and their potential market applications. Product development opportunities for clinical chemistry and immunodiagnostic instruments and consumables. Profiles of 25 current and ...
December 2012
561 pages
2013 Japan Clinical Chemistry and Immunodiagnostics Markets
US$ 5,440.00
... ten-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays ... and their potential market applications. Product development opportunities for clinical chemistry and immunodiagnostic instruments and consumables. Profiles of 25 current and ...
December 2012
559 pages
2013 Spain Clinical Chemistry and Immunodiagnostics Markets
US$ 4,320.00
... ten-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays ... and their potential market applications. Product development opportunities for clinical chemistry and immunodiagnostic instruments and consumables. Profiles of 25 current and ...
December 2012
568 pages
2013 UK Clinical Chemistry and Immunodiagnostics Markets
US$ 4,320.00
... ten-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays ... and their potential market applications. Product development opportunities for clinical chemistry and immunodiagnostic instruments and consumables. Profiles of 25 current and ...
December 2012
563 pages
2013 US Clinical Chemistry and Immunodiagnostics Markets
US$ 8,560.00
... ten-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays ... and their potential market applications. Product development opportunities for clinical chemistry and immunodiagnostic instruments and consumables. Profiles of 25 current and ...
December 2012
600 pages
2013 France Flow Cytometry Market: Opportunities and Strategies for Suppliers
US$ 2,880.00
... -page report from Venture Planning Group presents a comprehensive analysis of the French flow cytometry market, including: Major issues pertaining to the French ... . Five-year reagent and instrument sales forecasts. Sales and market shares of leading reagent and instrument suppliers. Review of current and ...
December 2012
146 pages
2013 Germany Flow Cytometry Market: Opportunities and Strategies for Suppliers
US$ 2,880.00
... -page report from Venture Planning Group presents a comprehensive analysis of the German flow cytometry market, including: Major issues pertaining to the German ... . Five-year reagent and instrument sales forecasts. Sales and market shares of leading reagent and instrument suppliers. Review of current and ...
December 2012
147 pages
2013 Italy Flow Cytometry Market: Opportunities and Strategies for Suppliers
US$ 2,880.00
... -page report from Venture Planning Group presents a comprehensive analysis of the Italian flow cytometry market, including: Major issues pertaining to the Italian ... . Five-year reagent and instrument sales forecasts. Sales and market shares of leading reagent and instrument suppliers. Review of current and ...
December 2012
142 pages
2013 Japan Flow Cytometry Market: Opportunities and Strategies for Suppliers
US$ 3,600.00
... page report from Venture Planning Group presents a comprehensive analysis of the Japanese flow cytometry market, including: Major issues pertaining to the Japanese ... . Five-year reagent and instrument sales forecasts. Sales and market shares of leading reagent and instrument suppliers. Review of current and ...
December 2012
142 pages
2013 Spain Flow Cytometry Market: Opportunities and Strategies for Suppliers
US$ 2,880.00
... -page report from Venture Planning Group presents a comprehensive analysis of the Spanish flow cytometry market, including: Major issues pertaining to the Spanish ... . Five-year reagent and instrument sales forecasts. Sales and market shares of leading reagent and instrument suppliers. Review of current and ...
December 2012
140 pages
2013 UK Flow Cytometry Market: Opportunities and Strategies for Suppliers
US$ 2,880.00
... new 146-page report from Venture Planning Group presents a comprehensive analysis of the UK flow cytometry market, including: Major issues pertaining to the ... systems. Five-year reagent and instrument sales forecasts. Sales and market shares of leading reagent and instrument suppliers. Review of current and ...
December 2012
146 pages
2013 US Flow Cytometry Market: Opportunities and Strategies for Suppliers
US$ 4,720.00
... new 174-page report from Venture Planning Group presents a comprehensive analysis of the US flow cytometry market, including: Major issues pertaining to the ... systems. Five-year reagent and instrument sales forecasts. Sales and market shares of leading reagent and instrument suppliers. Review of current and ...
December 2012
174 pages
2013 France Tumor Marker Testing Market: Opportunities and Strategies for Suppliers
US$ 4,320.00
Highlights This new 585-page analysis of the French tumor marker testing market report from Venture Planning Group including: Major ... installed base of automated and semi-automated analyzers used for tumor marker testing. Current instrumentation technologies and feature comparison of leading analyzers. ...
December 2012
585 pages
2013 Italy Tumor Marker Testing Market: Opportunities and Strategies for Suppliers
US$ 4,320.00
Highlights This new 570-page analysis of the Italian tumor marker testing market report from Venture Planning Group including: Major ... installed base of automated and semi-automated analyzers used for tumor marker testing. Current instrumentation technologies and feature comparison of leading analyzers. ...
December 2012
570 pages
2013 Germany Tumor Marker Testing Market: Opportunities and Strategies for Suppliers
US$ 4,320.00
Highlights This new 585-page analysis of the German tumor marker testing market report from Venture Planning Group including: Major ... installed base of automated and semi-automated analyzers used for tumor marker testing. Current instrumentation technologies and feature comparison of leading analyzers. ...
December 2012
585 pages
2013 Japan Tumor Marker Testing Market: Opportunities and Strategies for Suppliers
US$ 5,360.00
Highlights This new 590-page analysis of the Japanese tumor marker testing market report from Venture Planning Group including: Major ... installed base of automated and semi-automated analyzers used for tumor marker testing. Current instrumentation technologies and feature comparison of leading analyzers. ...
December 2012
590 pages
2013 Spain Tumor Marker Testing Market: Opportunities and Strategies for Suppliers
US$ 4,320.00
Highlights This new 565-page analysis of the Spanish tumor marker testing market report from Venture Planning Group including: Major ... installed base of automated and semi-automated analyzers used for tumor marker testing. Current instrumentation technologies and feature comparison of leading analyzers. ...
December 2012
595 pages
2013 UK Tumor Marker Testing Market: Opportunities and Strategies for Suppliers
US$ 4,320.00
Highlights This new 575-page analysis of the UK tumor marker testing market report from Venture Planning Group including: Major issues ... installed base of automated and semi-automated analyzers used for tumor marker testing. Current instrumentation technologies and feature comparison of leading analyzers. ...
December 2012
575 pages
2013 US Tumor Marker Testing Market: Opportunities and Strategies for Suppliers
US$ 6,960.00
Highlights This new 620-page analysis of the US tumor marker testing market report from Venture Planning Group including: Major issues ... installed base of automated and semi-automated analyzers used for tumor marker testing. Current instrumentation technologies and feature comparison of leading analyzers. ...
December 2012
620 pages
2013 CEA Testing Market: US, Europe, Japan Test Volume, Sales Forecasts and Supplier Shares by Country
US$ 3,080.00
... report from Venture Planning Group presents a detailed analysis of the CEA testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, ... disease. During the next ten years, the worldwide cancer testing market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated ...
December 2012
250 pages
2013 Occult Blood Testing Market: US, Europe, Japan Test Volume and Sales Forecasts by Country
US$ 3,080.00
... from Venture Planning Group presents a detailed analysis of the Occult Blood testing market in the US, Europe (France, Germany, Italy, Spain, UK) and ... the disease. During the next ten years, the worldwide cancer testing market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated ...
December 2012
243 pages
2013 Pap Smear/HPV Testing Market: US, Europe, Japan Test Volume and Sales Forecasts by Country
US$ 3,080.00
... from Venture Planning Group presents a detailed analysis of the Pap Smear/HPV testing market in the US, Europe (France, Germany, Italy, Spain, UK) and ... the disease. During the next ten years, the worldwide cancer testing market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated ...
December 2012
243 pages
2013 PSA Testing Market: US, Europe, Japan Test Volume, Sales Forecasts and Supplier Shares by Country
US$ 3,080.00
... report from Venture Planning Group presents a detailed analysis of the PSA testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, ... disease. During the next ten years, the worldwide cancer testing market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated ...
December 2012
249 pages